William E. Friedrichs

3.6k total citations
46 papers, 3.0k citations indexed

About

William E. Friedrichs is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, William E. Friedrichs has authored 46 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Epidemiology. Recurrent topics in William E. Friedrichs's work include Herpesvirus Infections and Treatments (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). William E. Friedrichs is often cited by papers focused on Herpesvirus Infections and Treatments (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). William E. Friedrichs collaborates with scholars based in United States, Belgium and India. William E. Friedrichs's co-authors include Linda A. deGraffenried, Manuel Hidalgo, Charles Grose, Viktor Grünwald, Jessica Silva-Fisher, Ratna B. Ray, Karen Block, Elissa J. Donzis, B. K. Nayak and Letitia C. Fulcher and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

William E. Friedrichs

46 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William E. Friedrichs United States 27 1.5k 724 604 470 394 46 3.0k
Konstantin Christov United States 30 2.0k 1.3× 1.2k 1.6× 577 1.0× 521 1.1× 265 0.7× 100 3.7k
Catherine A. Reznikoff United States 28 2.2k 1.5× 977 1.3× 549 0.9× 925 2.0× 331 0.8× 70 4.1k
Javier Corral Spain 37 1.4k 0.9× 328 0.5× 445 0.7× 507 1.1× 558 1.4× 235 5.2k
Patricia V. Schoenlein United States 31 1.7k 1.1× 809 1.1× 502 0.8× 374 0.8× 119 0.3× 60 3.0k
Maria Vittoria Barone Italy 39 2.3k 1.5× 919 1.3× 793 1.3× 392 0.8× 453 1.1× 120 4.8k
Teruhiko Tamaya Japan 34 1.5k 1.0× 613 0.8× 1.2k 2.0× 327 0.7× 175 0.4× 290 4.3k
Scott D. Cramer United States 35 1.6k 1.0× 677 0.9× 504 0.8× 788 1.7× 924 2.3× 72 3.3k
Herbert K. Oie United States 33 2.1k 1.4× 1.4k 1.9× 807 1.3× 600 1.3× 888 2.3× 71 4.4k
Brian K. Dieckgraefe United States 33 1.4k 0.9× 684 0.9× 914 1.5× 352 0.7× 169 0.4× 64 3.4k
Gaétan Mayer Canada 28 1.2k 0.8× 440 0.6× 334 0.6× 373 0.8× 134 0.3× 65 3.3k

Countries citing papers authored by William E. Friedrichs

Since Specialization
Citations

This map shows the geographic impact of William E. Friedrichs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Friedrichs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Friedrichs more than expected).

Fields of papers citing papers by William E. Friedrichs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Friedrichs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Friedrichs. The network helps show where William E. Friedrichs may publish in the future.

Co-authorship network of co-authors of William E. Friedrichs

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Friedrichs. A scholar is included among the top collaborators of William E. Friedrichs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Friedrichs. William E. Friedrichs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shanmugasundaram, Karthigayan, B. K. Nayak, William E. Friedrichs, et al.. (2017). NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance. Nature Communications. 8(1). 997–997. 176 indexed citations
2.
Pauleikhoff, Daniel, Bernd Bertram, Bernd Kirchhof, et al.. (2013). Die Anti-VEGF-Therapie bei der neovaskulären altersabhängigen Makuladegeneration: Therapeutische Strategien Stand Dezember 2012. Klinische Monatsblätter für Augenheilkunde. 230(2). 170–177. 12 indexed citations
3.
Fitzgerald, John P., B. K. Nayak, Karthigayan Shanmugasundaram, et al.. (2012). Nox4 Mediates Renal Cell Carcinoma Cell Invasion through Hypoxia-Induced Interleukin 6- and 8- Production. PLoS ONE. 7(1). e30712–e30712. 88 indexed citations
4.
Nayak, B. K., Denis Féliers, Sunil Sudarshan, et al.. (2012). Stabilization of HIF-2α through redox regulation of mTORC2 activation and initiation of mRNA translation. Oncogene. 32(26). 3147–3155. 43 indexed citations
5.
Friedrichs, William E., Shivani Ruparel, Robert A. Marciniak, & Linda A. deGraffenried. (2011). Omega-3 Fatty Acid Inhibition of Prostate Cancer Progression to Hormone Independence Is Associated With Suppression of mTOR Signaling and Androgen Receptor Expression. Nutrition and Cancer. 63(5). 771–777. 41 indexed citations
6.
Silva-Fisher, Jessica, David Cavazos, Elissa J. Donzis, et al.. (2007). Akt-Induced Tamoxifen Resistance is Associated with Altered FKHR Regulation. Cancer Investigation. 25(7). 569–573. 8 indexed citations
7.
deGraffenried, Linda A., Letitia C. Fulcher, William E. Friedrichs, et al.. (2004). Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway. Annals of Oncology. 15(10). 1510–1516. 145 indexed citations
8.
deGraffenried, Linda A., Bysani Chandrasekar, William E. Friedrichs, et al.. (2004). NF-κB inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Annals of Oncology. 15(6). 885–890. 111 indexed citations
9.
deGraffenried, Linda A., William E. Friedrichs, Douglas Russell, et al.. (2004). Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells with Aberrant Akt Activity. Clinical Cancer Research. 10(23). 8059–8067. 324 indexed citations
10.
deGraffenried, Linda A., William E. Friedrichs, Letitia C. Fulcher, et al.. (2003). Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Annals of Oncology. 14(7). 1051–1056. 58 indexed citations
11.
Hilsenbeck, Susan G., William E. Friedrichs, Rachel Schiff, et al.. (1999). Statistical Analysis of Array Expression Data as Applied to the Problem of Tamoxifen Resistance. JNCI Journal of the National Cancer Institute. 91(5). 453–459. 143 indexed citations
12.
Yang, Feifei, William E. Friedrichs, Linda A. deGraffenried, et al.. (1996). Cellular Expression of Ceruloplasmin in Baboon and Mouse Lung During Development and Inflammation. American Journal of Respiratory Cell and Molecular Biology. 14(2). 161–169. 29 indexed citations
13.
Friedrichs, William E., et al.. (1995). Expression and Inflammatory Regulation of Haptoglobin Gene in Adipocytes. Biochemical and Biophysical Research Communications. 209(1). 250–256. 110 indexed citations
14.
Linehan, Leslie A., et al.. (1993). Characterization of the Mouse Haptoglobin Gene. Genomics. 18(2). 374–380. 21 indexed citations
15.
Yang, Funmei, et al.. (1992). Human α2-HS-glycoprotein/bovine fetuin homologue in mice: identification and developmental regulation of the gene. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1130(2). 149–156. 45 indexed citations
16.
Friedrichs, William E., et al.. (1991). Extrahepatic expression of plasma protein genes during inflammation. Inflammation. 15(5). 369–379. 87 indexed citations
17.
Yang, Funmei, William E. Friedrichs, James M. Buchanan, et al.. (1990). Tissue specific expression of mouse transferrin during development and aging. Mechanisms of Ageing and Development. 56(2). 187–197. 34 indexed citations
18.
Friedrichs, William E. & Charles Grose. (1984). Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography. Journal of Virology. 49(3). 992–996. 14 indexed citations
19.
Grose, Charles, et al.. (1981). Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus. Infection and Immunity. 31(3). 1044–1053. 18 indexed citations
20.
Harper, M. J. K., et al.. (1980). Effect of endotoxin treatment on prostaglandin metabolism by rabbit uterus and oviduct. Reproduction. 58(1). 101–108. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstantin Christov Breakdown of academic impact, for papers by Catherine A. Reznikoff Breakdown of academic impact, for papers by Javier Corral Breakdown of academic impact, for papers by Patricia V. Schoenlein Breakdown of academic impact, for papers by Maria Vittoria Barone Breakdown of academic impact, for papers by Teruhiko Tamaya Breakdown of academic impact, for papers by Scott D. Cramer Breakdown of academic impact, for papers by Herbert K. Oie Breakdown of academic impact, for papers by Brian K. Dieckgraefe Breakdown of academic impact, for papers by Gaétan Mayer
Rankless by CCL
2026